Mats Remberger

Author information from the last article

Avdeling for blodsykdommer

Oslo universitetssykehus

Klinisk forsknings- og utviklingsenhet

Blod og svulstsykdommer

Uppsala universitetssykehus

Institutt for medisinsk vitenskap

Uppsala universitet

Forfatterbidrag: skriving av statistikkdelen, statistisk analyse, utforming av figurer, tolkning av data, litteratursøk, revisjon og godkjenning av manusrevisjoner.

Mats Remberger er professor.

Articles by Mats Remberger

Allogeneic stem cell transplantation for patients with lymphoma 2011–21

Hege Melby Frøen,
Marianne Brodtkorb,
Harald Holte,
Arne Kolstad,
Anders Eivind Myhre,
Mats Remberger,
Geir Erland Tjønnfjord,
Tobias Gedde-Dahl

03.03.2025: Allogeneic stem cell transplantation (ASCT) is potentially curative for patients with haematologic malignancies, lymphomas and certain non-malignant conditions. However, it carries a risk of severe complications and transplant-related mortality due to organ damage, infection and graft-versus-host...

Allogeneic stem cell transplantation in adults 2015–21

Camilla Dao Vo,
Anders Eivind Myhre,
Ingerid Weum Abrahamsen,
Mats Remberger,
Jonas Mattsson,
Yngvar Fløisand,
Bjørn Christer Linder Grønvold,
Geir Erland Tjønnfjord,
Tor Henrik Anderson Tvedt,
Tobias Gedde-Dahl

14.03.2023: Allogeneic stem cell transplantation is the only curative treatment for a number of malignant haematological diseases and congenital or acquired immunodeficiencies. In allogeneic stem cell transplantation, the patient's own bone marrow is destroyed following pre-transplant treatment with high-dose...